↓ Skip to main content

Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
4 X users
patent
1 patent

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
10 Mendeley